CytoHealth

05/03/2026

This year, we’re proud to mark the 𝟱𝘁𝗵 𝗮𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝗼𝗳 𝗖𝘆𝘁𝗼𝗛𝗲𝗮𝗹𝘁𝗵 at a pivotal moment for fostering leadership in the bioprocessing sector.

To celebrate this remarkable milestone, we gathered to toast to our achievements and the journey we’ve built together. Over the past five years, we’ve navigated challenges, embraced learning, and grown as one. Every moment reflects the dedication, collaboration, and people who have shaped our journey.

As remark shared by 𝗗𝗿. 𝗟𝗶𝘆𝗶𝗻 𝗪𝗼𝗻𝗴, 𝗖𝗘𝗢 𝗼𝗳 𝗖𝘆𝘁𝗼𝗛𝗲𝗮𝗹𝘁𝗵, in her deep gratitude: "The success of CytoHealth is inseparable from the hard work and dedication of the entire team. Every meaningful impact shall begin with passion, and it is through working on the details that passion turns into real results. CytoHealth is not merely a building or a laboratory, but the spirit of innovation. And this is what makes the organization what it is today."

𝗛𝗲𝗿𝗲’𝘀 𝘁𝗼 𝗼𝘂𝗿 𝗻𝗲𝘅𝘁 𝗰𝗵𝗮𝗽𝘁𝗲𝗿 𝗼𝗳 𝗴𝗿𝗼𝘄𝘁𝗵.🌟
𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗮𝘀 𝘄𝗲 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺.

02/03/2026

Congratulations to the new council lineup, including our CSO, Dr. Daniel Looi. Together, we looking forward to a continued growth of stem cell and regenerative medicine ecosystem in Malaysia.💪

28/02/2026

𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗹𝗼𝗼𝗸 𝗹𝗶𝗸𝗲 𝗶𝗻 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲? 𝗙𝗼𝗿 𝘂𝘀, 𝗶𝘁 𝗹𝗼𝗼𝗸𝗲𝗱 𝗹𝗶𝗸𝗲 𝗮 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝗼𝗳 𝗱𝗲𝗲𝗽 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗼𝘂𝗿 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 𝗮𝘁 Esco Lifesciences Group.

We started the month with a hands-on demonstration session by Esco Malaysia team at our HQ, followed by our visit to Esco Aster facility in Singapore for insightful technical discussions. The sessions focused on exploring technologies that strengthen process control across our biologics development pipeline.

The goal? To enhance reliability, standardization, and translation readiness for real-world applications. We're excited to leverage these enabling technologies into our bioprocessing platform as we continue advancing evidence-based regenerative solutions.

28/02/2026

𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲🌟
Congratulations to our CSO, Dr. Daniel Looi on his appointment, a recognition of his leadership, dedication, and continued contributions to advancing scientific research.

26/02/2026

A heartiest congratulation to our Chief Scientific Officer, Dr. Daniel Looi, on being elected as an Associate Member of Sigma Xi, The Scientific Research Honor Society, one of the world’s oldest and most prestigious interdisciplinary scientific organizations, with more than 200 Nobel Prize winners among its members. We also proud to announce his appointment as a Council Member of the Malaysian Society for Stem Cell Research and Therapy (MSCRT)

These recognitions reflect his rigorous contributions, pioneering leadership in regenerative medicine, and his continued commitment to advancing research, fostering scientific exchange, and strengthening research translation that impacts the field, particularly in stem cell and exosomes science.

CytoHealth celebrates this honor and congratulates Dr. Daniel. This milestone fuels our passion and keeps us devoted to advancing regenerative science, striving for evidence-based excellence. 💪

24/02/2026

𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗖𝗡𝗬 𝘁𝗵𝗲 𝗖𝘆𝘁𝗼𝗛𝗲𝗮𝗹𝘁𝗵 𝘄𝗮𝘆 🐎🧧
Laughter bounced around, lou sang was tossed high, and wishes filled the air🍊

Celebrating Chinese New Year together made every moment brighter, every smile bigger, and every memory sweeter—here’s to a year full of joy, laughter, and all the good things ahead!

𝗬𝗲𝗮𝗿 𝗼𝗳 𝗛𝗼𝗿𝘀𝗲, 𝗔 𝗬𝗲𝗮𝗿 𝗼𝗳 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲𝘀 𝗔𝗵𝗲𝗮𝗱✨

17/02/2026

𝗚𝗮𝗹𝗹𝗼𝗽𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿 𝗼𝗳 𝘁𝗵𝗲 𝗛𝗼𝗿𝘀𝗲 🐎🧧
CytoHealth wishes everyone a prosperous Chinese New Year! May the Year of the Horse bring good health, happiness, and renewed energy — carrying you forward with strong momentum, steady progress, and success in every stride.

𝗬𝗲𝗮𝗿 𝗼𝗳 𝗛𝗼𝗿𝘀𝗲, 𝗔 𝗬𝗲𝗮𝗿 𝗼𝗳 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲𝘀 𝗔𝗵𝗲𝗮𝗱✨

16/02/2026

We recently had a productive and insightful meet-up with Dr. Vivek from Disruptive Doctors which was filled with exciting ideas and shared ambitions. We look forward to creating meaningful disruptive impact together—and are excited to see the change that DD Con 2026 will bring this year!

13/02/2026

Keeping the momentum with continuous 𝗘𝘅𝗼𝗶𝗱 training that took place on 11–12 February, but this time with Dr. Raphael Cedric Diputado from Izon Science joining us in person at CytoHealth (HQ) to guide us for a hands-on technical demonstration.🤩

With Exoid and its 𝗧𝗥𝗣𝗦 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 now fully integrated into our workflows, we’re leveraging the platform to take 𝗲𝘅𝗼𝘀𝗼𝗺𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 to the next level!

#2026

10/02/2026

In regenerative medicine, scientific novelty alone is no longer enough. Translation readiness is now the key differentiator, where impact begins only when innovation move beyond the laboratory.

This perspective shaped our recent discussion with research partners from Taylor's University and Monash University Malaysia on 3 February 2026 at CytoHealth (HQ), arising from our recently granted cross-collaboration patents in 𝗲𝘅𝗼𝘀𝗼𝗺𝗲𝘀 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 and 𝘀𝗸𝗶𝗻-𝘄𝗵𝗶𝘁𝗲𝗻𝗶𝗻𝗴 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀. The conversation focused on the potential commercialization of these scientific breakthroughs and on how they can be responsibly translated into industry-ready solutions to deliver system-level impact.

We were honored to host distinguished partners, including Ts. Mr. Roydean Osman, Vice President of Innovation & Commercialisation at Taylor’s University, and Mr. Kian Giap L., Grants & Commercialisation Lead of the Research Excellence Unit at Monash University, together with their teams. Our dialogue reaffirmed that true progress lies not just in novel innovation, but in a united research-industry collaboration committed to delivering sustainable outcomes for the future of regenerative healthcare.

09/02/2026

Proudly supporting the Seminar Series 2026, which sparks meaningful conversations by bringing together international and local regenerative medicine expertise. Let’s kick-start the conversation tomorrow! ✨

🚀 Invitation to the MSCRT Seminar Series 1/2026 🌏

Join us for the MSCRT Seminar Series 1/2026, held in conjunction with the 8th MSCRT Seminar 2026! 3 prominent speakers in the field will share the latest updates in stem cell research and therapy. We look forward to a session that will spark collaborations and shape the future of regenerative medicine!

Register Now!

🌏MSCRT Seminar Series 1/2026 🌏
📅 Date: Tuesday, 10 February 2026
🕘 Time: 11:00 AM – 1:00 PM (Malaysia Time)
💻 Mode: Online via Google Meet
💵 Registration Fee: FREE
🔗 Register here: https://forms.gle/22pwxqMz1RDH6mcu6

📢Tag your colleagues, invite your network, and join us in this seminar!

Malaysian Society for Stem Cell Research and Therapy, CytoHealth, ,

04/02/2026

Heartiest congratulations to our Chief Scientific Officer, 𝗗𝗿. Daniel Looi on his renewal of appointment as 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗙𝗲𝗹𝗹𝗼𝘄 (𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆) at the Department of Tissue Engineering & Regenerative Medicine, UKM, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM) for his second term.

This prestigious appointment reflects strong recognition of Dr. Daniel’s scientific leadership, expertise, and continued contributions to the advancement of 𝗿𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲, as well as his commitment to strengthening industry–academia collaboration.

We are proud to see his work contribute meaningfully to translational research, innovation, and the future of regenerative healthcare. Wishing Dr. Daniel continued success and impactful achievements throughout his term!